hero section gradient
17 handpicked stocks

Century Club

These companies have stood the test of time for over 100 years. Carefully selected by our analysts, this collection showcases businesses with proven resilience, established market positions, and the ability to deliver returns across multiple economic cycles.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Analysis of the Century Club basket total market capitalisation and stock breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility, greater stability, and closer tracking of broad market movements.
  • Use this basket primarily as a diversified core holding rather than a speculative, high-growth allocation.
  • Expect steady long-term appreciation tendencies rather than explosive short-term gains; outcomes are not guaranteed.
Total Market Cap
  • KO: $306.39B

  • JPM: $816.92B

  • PG: $354.86B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection represents corporate longevity champions that have weathered everything from world wars to the digital revolution. Their demonstrated ability to adapt through profound economic shifts and technological changes offers a unique form of stability that's rare in today's market.

2

What You Need to Know

Century Club companies span foundational sectors like manufacturing, transportation, consumer goods, and financial services. They typically feature strong brand recognition, established supply chains, and significant pricing power—advantages that help them navigate inflation and market uncertainty.

3

Why These Stocks

Each company was specifically selected for maintaining continuous operations for over 100 years—an extraordinary achievement that demonstrates sustainable business models and strategic adaptability. In a portfolio, they can provide a stabilizing element against market volatility.

Why You'll Want to Watch These Stocks

🛡️

Recession-Tested Winners

These companies have survived the Great Depression, multiple recessions, and market crashes. Their proven resilience makes them particularly attractive during economic uncertainty.

💰

Dividend Dynamos

Many Century Club companies have paid consistent dividends for decades, some for over 100 consecutive years. This income potential adds another dimension to their investment appeal.

🏆

The 1% Club

Less than 1% of companies survive a century of operation. These rare businesses have demonstrated exceptional staying power that countless competitors couldn't match.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions